Phase 1 Clinical Trial of Aflibercept (Eylea®) Biosimilar Completed by Alteogen

Published date05 April 2021
Subject MatterClinical Trials,Prescription Drugs,Biosimilars,Pharmaceutical Industry
Law FirmGoodwin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT